Bulls & Betrayal

Civitas Resources $CIVI promised strong production and growth—but behind the scenes, well counts dropped, debt ballooned, and executives vanished. In this episode of Bulls & Betrayal, we expose how upbeat forecasts masked real operational decline and why investors are now suing over sudden stock losses and surprise layoffs. If you’re into energy markets, corporate accountability, or just love a good Wall Street takedown, this o...

Biotech hopeful Iovance $IOVA promised a blockbuster launch of its cancer drug Amtagvi—forecasting nearly half a billion in revenue. But when reality hit, it came crashing down. In this episode of Bulls & Betrayal, we uncover how lofty projections, slow treatment rollout, and alleged internal knowledge of infrastructure issues led to a brutal 45% stock plunge. Ideal for investors, healthcare analysts, and corporate truth-seeker...

Red Cat Holdings $RCAT soared on drone hype, military contracts, and big promises—but now it’s facing investor lawsuits, insider sell-offs, and claims of massive exaggeration. In this episode of Bulls & Betrayal, we unpack the alleged deception behind “thousands of drones,” a $260M contract fantasy, and a reality crash that clipped investor wings. Ideal for investors, military-tech watchers, and truth seekers. Expect sharp stor...

DoubleVerify $DV claimed to protect brands from bot traffic—but now it’s accused of billing for ads shown to obvious bots and losing major clients. In this episode of Bulls & Betrayal, we dive into a digital deception unraveling across Wall Street. Perfect for adtech skeptics, investors, and truth-hunters who want the real story behind stock drops and lawsuits. Expect insider analysis, sharp wit, and zero fluff.

We’re not lawye...

Krispy Kreme $DNUT said investors would be "rolling in the dough"—but now it’s lawsuits and losses. This episode of Bulls & Betrayal dives into the frosted fiasco behind the $33 million miss and tanking stock. Perfect for retail investors, finance sleuths, and anyone craving corporate accountability. Expect sharp banter, deep dives, and a dash of comedy.

We’re not lawyers or accountants, so don’t take this as legal or financial...

When $CAR Avis Budget Group accelerated its fleet rotation strategy, it didn’t just switch out cars—it wiped nearly $2 billion off the books in one quarter. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, we break down the class action lawsuit accusing Avis of misleading investors by hiding the true financial impact of its fleet decisions. Perfect for investors, finance pros, and corporate accountability w...

Organon $OGN promised investors dividends were priority number one—then slashed payouts by over 70%. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, we dig into the lawsuit claiming Organon misled shareholders while quietly shifting gears to pay down debt. If you’re into dividend stocks, corporate trust, or securities law drama, this episode’s for you. Expect sharp commentary and deep dives.

We’re not lawy...

A major class action lawsuit is rocking $BITF Bitfarms Ltd, the Bitcoin mining company accused of misclassifying over $129 million in crypto proceeds and misleading investors about internal financial controls. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, Cassie and Bill break down what Bitfarms allegedly did wrong, who’s suing, and what this could mean for the crypto mining industry. Perfect for crypto ...

Ever read a securities lawsuit and feel like it's written in code? In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate decode the essential legal lingo like 10b-5, scienter, materiality, and loss causation that powers shareholder lawsuits. Whether you're an investor, law student, or just curious how the financial system polices itself, this episode is your go-to translation guide.

We’re not lawyers...

Ever wonder why some CEOs get sued while others get cuffed? In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate unpack the crucial difference between civil and criminal cases in securities fraud. From class actions to DOJ indictments, they explore how intent, evidence, and consequences define the legal response. Perfect for investors, law students, and true crime meets finance fans.

We’re not lawye...

In this episode of Bulls and Betrayal: Holding Wall Street Accountable, we dive into the courtroom role of expert witnesses in securities fraud cases. From economic loss models to industry insights, these finance-savvy pros can make or break billion-dollar lawsuits. Whether you're an investor, law junkie, or just curious how fraud cases unfold, we’ve got sharp analysis and plain-English breakdowns.

We’re not lawyers or accountants,...

When shady spreadsheets meet their match, forensic accountants step in. In this episode of Bulls and Betrayal: Holding Wall Street Accountable, we break down the role of these financial sleuths in exposing securities fraud. From fake invoices to sham revenue, these experts uncover the truth behind the numbers. Ideal for investors, legal buffs, and finance pros. Expect real-world examples, expert insights, and some serious accountin...

West Pharmaceutical $WST took a brutal 38% hit in one day after investors learned the company’s golden goose its SmartDose line was dragging profits, not boosting them. In this episode of Bulls and Betrayal: Holding Wall Street Accountable, we unpack how upbeat earnings calls masked a structural downturn and shrinking contracts, sparking a major securities class action. Perfect for biotech investors, analysts, and market skeptics. ...

Digimarc $DMRC shocked the market with a 43% stock drop after revealing a lost $5.8M contract they'd failed to disclose for months. In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Cassie and Bill break down the alleged cover-up, the class action lawsuit, and what it means for tech investors. Perfect for shareholders, finance buffs, and legal junkies. Expect deep dives, sharp banter, and no-fluff facts.

We’re...

In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Cassie and Bill unpack the explosive story behind Compass Diversified’s luxury brand Lugano Diamonds. Once hailed as a crown jewel, $CODI stock plummeted over 60% amid federal class action allegations of misleading investors, flawed financial controls, and a shocking CEO resignation. Perfect for investors, finance enthusiasts, and corporate watchdogs. Expect sh...

When buzzwords meet balance sheets, things can go south fast. In this episode of Bulls & Betrayal, Cassie and Bill unpack the class action against $IBTA Ibotta after its alleged failure to disclose a key contract risk involving grocery giant Kroger. Investors claim they were misled during the flashy IPO. If you’re into financial drama, Wall Street accountability, or just want the lowdown on how IPOs can unravel, this is for you...

GlaxoSmithKline $GSK allegedly hid a decades-old report showing its blockbuster drug Zantac could form a cancer-causing compound far beyond safe limits. Now, a securities class action says $GSK misled investors for years while lawsuits mounted. In this explosive episode of Bulls and Betrayal, Anna and Nate expose the cover-up, the internal science, and the $2.3B market hit. For pharma investors, legal junkies, and anyone who’s ever...

Ultra Clean Holdings $UCTT promised explosive semiconductor growth in China—then stunned the market with a surprise earnings drop and a 28% stock plunge. On this episode of Bulls and Betrayal, Anna and Nate dig into the class action lawsuit alleging $UCTT hid slowdowns, inventory issues, and customer ramp failures behind bullish calls and inflated forecasts. For tech investors, market skeptics, and finance truth-seekers, this is mu...

Solaris Energy Infrastructure $SEI turned heads with a $400M acquisition—of a company with no employees, no real assets, and ties to a convicted felon. In this episode of Bulls and Betrayal, Anna and Nate dissect the shocking class action lawsuit alleging Solaris misled investors about MER’s legitimacy, cooked depreciation math, and hid toxic baggage (literally). Perfect for shareholders, corporate governance junkies, and true cri...